Conference Coverage

Risk factors ID’d for acute pancreatitis from weight-loss drugs


 

FROM ACG 2022

Larger studies needed

The study is “promising,” said session comoderator Baharak Moshiree, MD, a gastroenterologist at Atrium Health, Charlotte, N.C., who was not affiliated with the research.

However, because the study was retrospective and relatively small, it needs to be validated in larger, prospective studies, she added.

“With obesity being such a global issue, there are many patients on these GLP-1 agonists,” Dr. Moshiree said.

Generally, these medications are prescribed by endocrinologists, not gastroenterologists, she noted, and she said that gastroenterologists should be aware of the risks associated with them, including minor gastrointestinal side effects, like nausea and vomiting, that can occur because of delayed gastric emptying.

Dr. Postlethwaite noted that being unable to assess how much alcohol or tobacco individuals used was a limitation. The relatively low proportion of people who developed acute pancreatitis in the study also means larger studies are warranted, he added.

Going forward, Dr. Postlethwaite and colleagues want to study the risks for each individual GLP-1 and other therapies used to control high blood sugar in people with type 2 diabetes, such as DPP4 (dipeptidyl-peptidase 4) inhibitors.

The study was independently supported. Dr. Postlethwaite and Dr. Moshiree report no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Bariatric surgery may up risk for epilepsy
MDedge Internal Medicine
Food insecurity a growing problem for many with CVD
MDedge Internal Medicine
Eating earlier offers health benefits, studies say
MDedge Internal Medicine
Bariatric surgery prompts visceral fat reduction, cardiac changes
MDedge Internal Medicine
Playing the fat shame game in medicine: It needs to stop
MDedge Internal Medicine
Tirzepatide’s benefits expand: Lean mass up, serum lipids down
MDedge Internal Medicine
Weight loss history affects success in obesity management
MDedge Internal Medicine
It’s about location: PCOS symptoms differ depending where you live
MDedge Internal Medicine
New AGA guidelines advise use of antiobesity medications for weight management
MDedge Internal Medicine
Don’t be afraid of weight gain with hyperthyroid treatment
MDedge Internal Medicine